Over the past two years, malaria has become a vaccine-preventable disease thanks to the approval of two innovative vaccines.
The World Health Organization (WHO) now recommends that children in certain areas receive four doses of GSK's Mosquirix™ (RTS,S/AS01) malaria vaccine, the world's first approved malaria vaccine.
As of May 2024, Mosquirix is available in African countries but not in the United States.
Read More
